Sarepta Therapeutics, Inc.

By person

30 insiders · 178 transactions

13.5×

Douglas S. Ingram holds 13.5 times base salary in stock. $15.82M of shares against $1.17M in salary for 2025.

Salary from the company's own proxy. The shares are what Douglas S. Ingram last reported holding, valued at $17.02, the price Common Stock was last bought or sold at on the open market here, on 12 Mar 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Mahatme Sandesh

EVP, CFO & CBO

—

$50.87M (9) scheduled

−$50.87M

44,284

0.0419%

$753.71K

+131.7%

Howton David T

EVP, General Counsel

—

$43.31M (17) scheduled

−$43.31M

31,871

0.0302%

$542.44K

+906.0%

Chambers Michael Andrew

Director

$23.27M (14)

—

+$23.27M

311,569

0.2950%

$5.30M

+314.4%

INGRAM DOUGLAS S

Chief Executive Officer

$14.02M (12)

—

+$14.02M

929,391

0.8799%

$15.82M

—

Barry Richard

Director

$5.49M (7)

$18.77M (5)

−$13.28M

3,123,542

2.96%

$53.16M

0.0%

Cumbo Alexander

EVP, Chief Commercial Officer

—

$12.25M (8) scheduled

−$12.25M

12,008

0.0114%

$204.38K

−40.8%

Wigzell Hans Lennart Rudolf

Director

—

$11.03M (15) scheduled

−$11.03M

42,098

0.0399%

$716.51K

+643.0%

Brown Ryan Edward

EVP, General Counsel

—

$6.55M (8) scheduled

−$6.55M

17,129

0.0162%

$291.54K

+286.5%

Kaye Edward M. MD

Director

—

$4.04M (5) scheduled

−$4.04M

71,229

0.0674%

$1.21M

−7.5%

Arif Bilal

Chief Tech Ops Officer

—

$2.18M (8) scheduled

−$2.18M

32,500

0.0308%

$553.15K

+37.5%

Ruff Shamim

SVP, Chief Regulatory Affairs

—

$2.09M (6) scheduled

−$2.09M

31,936

0.0302%

$543.55K

+85.3%

Aphale Jayant

VP, Technical Operations

—

$1.75M (2) scheduled

−$1.75M

11,490

0.0109%

$195.56K

0.0%

BEHRENS M KATHLEEN

Director

$219.95K (1)

$1.75M (2) scheduled

−$1.53M

224,357

0.2124%

$3.82M

+85.2%

Estepan Ian Michael

Chief Operating Officer

—

$1.27M (3)

−$1.27M

177,184

0.1677%

$3.02M

+1,225%

Mayo Stephen

Director

—

$603.00K (3)

−$603.00K

18,640

0.0176%

$317.25K

—

Bratica Joseph

Principal Financial Officer

—

$538.35K (3) scheduled

−$538.35K

8,140

0.0077%

$138.54K

0.0%

Murray Dallan

Chief Customer Officer

—

$508.90K (1) scheduled

−$508.90K

38,202

0.0362%

$650.20K

+74.0%

Rodino-Klapac Louise

President, R&D and Tech Ops

$299.87K (1)

—

+$299.87K

203,900

0.1930%

$3.47M

+2,430%

Boor Kathryn Jean

Director

—

$298.95K (2)

−$298.95K

25,138

0.0238%

$427.85K

—

Nicaise Claude

Director

—

$248.20K (1) scheduled

−$248.20K

48,407

0.0458%

$823.89K

+4,741%

BONNEY MICHAEL W

Director

$173.48K (1)

—

+$173.48K

9,126

0.0086%

$155.32K

—

SEVERINO MICHAEL

Chief Executive Officer

—

756,104

0.7158%

$12.87M

—

Wong Ryan Ho-Yan

Chief Financial Officer

—

121,792

0.1153%

$2.07M

+589.8%

Rothfuss Cristin

EVP, General Counsel

—

115,519

0.1094%

$1.97M

+738.4%

O'Neill Gilmore Neil

EVP, R&D & CMO

—

29,070

0.0275%

$494.77K

—

Connelly Deirdre P

Director

—

22,100

0.0209%

$376.14K

—

Ciambrone William

EVP

—

22,099

0.0209%

$376.12K

+8,432%

GRAY MARY ANN

Director

—

12,356

0.0117%

$210.30K

+18,071%

MARTIN JOHN C

Director

—

7,913

0.0075%

$134.68K

—

Kress Jean-Paul

Director

—

2,000

0.0019%

$34.04K

+100.0%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Arif Bilal

25 Jun 2024

Chief Tech Ops Officer

Sold on a plan

3,898

$163.23

$636.27K

Arif Bilal

24 Jun 2024

Chief Tech Ops Officer

Sold on a plan

224

$167.13

$37.44K

Arif Bilal

24 Jun 2024

Chief Tech Ops Officer

Sold on a plan

700

$166.10

$116.27K

Arif Bilal

24 Jun 2024

Chief Tech Ops Officer

Sold on a plan

300

$164.61

$49.38K

Arif Bilal

24 Jun 2024

Chief Tech Ops Officer

Sold on a plan

1,055

$163.83

$172.84K

Arif Bilal

24 Jun 2024

Chief Tech Ops Officer

Sold on a plan

5,580

$162.31

$905.69K

Murray Dallan

2 May 2024

Chief Customer Officer

Sold on a plan

3,635

$140.00

$508.90K

Show all 178 transactions →

Sarepta Therapeutics, Inc.

By person

Individual transactions

What was left out